ReviewClinical therapeutics2009

A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.

Eduard Montanya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.